2023
Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study
Mooghali M, Glick L, Ramachandran R, Ross J. Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study. BMJ Open 2023, 13: e069115. PMID: 36690402, PMCID: PMC9872463, DOI: 10.1136/bmjopen-2022-069115.Peer-Reviewed Original Research
2016
Why the Open Payments Program Is Likely to Provide Systematic and Transparent Data on Financial Relationships with Industry
Fleischman W, Ross JS. Why the Open Payments Program Is Likely to Provide Systematic and Transparent Data on Financial Relationships with Industry. The American Journal Of Medicine 2016, 129: e193. PMID: 27554954, DOI: 10.1016/j.amjmed.2016.01.051.Commentaries, Editorials and LettersFinancial Ties Between Emergency Physicians and Industry: Insights From Open Payments Data
Fleischman W, Ross JS, Melnick ER, Newman DH, Venkatesh AK. Financial Ties Between Emergency Physicians and Industry: Insights From Open Payments Data. Annals Of Emergency Medicine 2016, 68: 153-158.e4. PMID: 26973175, DOI: 10.1016/j.annemergmed.2016.01.014.Peer-Reviewed Original Research
2015
Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011
Rathi VK, Krumholz HM, Masoudi FA, Ross JS. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011. JAMA 2015, 314: 604-612. PMID: 26262798, DOI: 10.1001/jama.2015.8761.Peer-Reviewed Original ResearchConceptsPrimary effectiveness end pointEffectiveness end pointPostmarket studiesClinical studiesClinical evidencePMA pathwayPremarket studiesEnd pointAvailable FDA documentsInitial marketing approvalPremarket approval pathwayTherapeutic devicesMedian durationMedian enrollmentHigh-risk medical devicesMAIN OUTCOMEPatientsDrug AdministrationUS FoodFDA approvalMarketing approvalLonger durationFDA documentsMonthsPostmarket